Skip to main content
Reproductive Health logoLink to Reproductive Health
. 2025 Mar 9;22:36. doi: 10.1186/s12978-025-01977-4

Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial

Haiyan Guo 1, Tong Du 1, Hongyuan Gao 1, Qianwen Xi 1, Ling Wu 1, Qifeng Lyu 1, Qianqian Zhu 1,
PMCID: PMC11892218  PMID: 40059192

Retraction Note: Reproductive Health (2022) 19:198 10.1186/s12978-022-01500-z

The Editors-in-Chief have retracted this article because it overlaps significantly with another article [1] from the same author group. Haiyan Guo, Hongyuan Gao, Qianwen Xi, Ling Wu, Qifeng Lyu and Qianqiun Zhu have not responded to correspondence from the Publisher about this retraction. Tong Du has stated that they were not aware of the submission of this article and did not participate in this study.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Guo H, Li J, Shen X, Cong Y, Wang Y, Wu L, Li B, Gao H, Ma M, Zhang W, Mao X, Fu Y, Lyu Q, Chai W, Kuang Y. Efficacy of different progestins in women with advanced endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization—a single-center non-inferiority randomized controlled trial. Front Endocrinol (Lausanne). 2020. 10.3389/fendo.2020.00129. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Reproductive Health are provided here courtesy of BMC

RESOURCES